Illustrative image – not actual.Dr Reddy's Laboratories is planning to invest Rs 1,000 crore to expand its capacity in the next financial year.
The company will utilise the proposed investment to expand its existing facilities as well as some greenfield projects.
Dr Reddy's, through its three businesses -- Pharmaceutical Services and Active Ingredients; Global Generics; and Proprietary Products, offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similar, differentiated formulations and NCEs.
In India, the company has one integrated product development facility in Hyderabad; six FDA-inspected plants; seven formulation plants (two USFDA inspected); and two technology development centres in Hyderabad.
